Lilly Researcher Shares Story on Alzheimers

Dr. Jan Lundberg, PH.D., executive VP science & technology and president Lilly research labs, shares his personal story first-hand about Alzheimers and underscores PhRMA (Pharmaceutical Research and Manufacturers of America)and Lilly's sentiment that new treatments for this fatal disease are needed to help patients and their caregivers, as well as lessen the burden on the healthcare system.

Category:

Science & Technology

Tags:

• Lilly
• PhRMA
• alzheimers
• disease
• dementia
• health care
• Alzheimer's Disease
• education
• innovation
• research
• lilly
• eli lilly
• patients
• healthcare system
• burden